About NGB Diagnostics Private Limited
Data last updated:
NGB Diagnostics Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 05 June 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2012PTC236945. Its GSTIN is 07AAECN4454E1ZL (Delhi). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rakesh Kumar Maurya and Amit Singh Rawat.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No.120 3rd Floor Hargovind Enclave, New Delhi, Delhi, India – 110092.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.93 Cr, a decline of 33% compared to the previous year. For the same year it recorded a net profit of ₹3.68 Lakh (net margin 1.9%) and EBITDA of ₹7.16 Lakh (EBITDA margin 3.7%). Revenue has grown at a compounded annual rate (CAGR) of 27% over three years and 14% over five years.
The company is associated with 1 brand: NGB Diagnostics. Court records list 9 cases involving the company, including 8 filed by the company and 1 filed against it; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website ngbdx.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressPlot No.120 3rd Floor Hargovind Enclave, New Delhi, Delhi, India – 110092
- IndustryHealthcare, Diagnostic Centers & Pathology Labs
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of NGB Diagnostics Private Limited
The main business activity of NGB Diagnostics is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of NGB Diagnostics Private Limited FY 2025 filings available
NGB Diagnostics Private Limited reported revenue of ₹1.93 Cr (down 33% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of NGB Diagnostics Private Limited
Revenue fell 33% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 14%. EBITDA rose 3% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of NGB Diagnostics Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹7.16 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹3.68 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of NGB Diagnostics Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of NGB Diagnostics are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of NGB Diagnostics Private Limited
NGB Diagnostics Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Diagnostics and Pathology Labs). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Trident Imaging & Diagnostics Centre Private Limited | ₹1.96 Cr (FY 2025) | •••• | •••• | 22.0% | •••• | Patna, Bihar, India |
| Fame Diagnostics & Health Care Private Limited | ₹1.95 Cr (FY 2025) | •••• | •••• | 24.0% | •••• | Bangalore, Karnataka, India |
| Chandrapur Imaging Centre and Medical Research Institute Private Limited | ₹1.95 Cr (FY 2024) | •••• | •••• | 39.0% | •••• | Chandrapur, Maharashtra, India |
| Newage Laboratories Limited | ₹1.93 Cr (FY 2021) | •••• | •••• | 16870.0% | •••• | Greater Noida, Uttar Pradesh, India |
| Neogen Diagnostics & Poly Clinic Private Limited | ₹1.93 Cr (FY 2023) | •••• | •••• | 24.0% | •••• | Rampurhat, West Bengal, India |
| NGB Diagnostics Private Limited this company | ₹1.93 Cr (FY 2025) | •••• | •••• | -33.0% | •••• | New Delhi, Delhi, India |
| PRK Rainbow Imaging and Diagnostics Private Limited | ₹1.93 Cr (FY 2025) | •••• | •••• | -20.0% | •••• | Karimnagar, Telangana, India |
| Elixir Diagnostics Private Limited | ₹1.92 Cr (FY 2022) | •••• | •••• | 104.0% | •••• | Chennai, Tamil Nadu, India |
| Quality Care Diagnostic Centre Private Limited | ₹1.92 Cr (FY 2025) | •••• | •••• | 5.0% | •••• | Chennai, Tamil Nadu, India |
| BG Diagnostics Private Limited | ₹1.92 Cr (FY 2025) | •••• | •••• | 14088.0% | •••• | Thane, Maharashtra, India |
| Sunayana Laser Vision Centre Private Limited | ₹1.92 Cr (FY 2024) | •••• | •••• | -7.0% | •••• | Chennai, Tamil Nadu, India |
Peers are the five companies nearest above and the five nearest below NGB Diagnostics by revenue in the Healthcare industry (Diagnostics and Pathology Labs), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of NGB Diagnostics Private Limited
NGB Diagnostics Private Limited is audited by N D R & ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| N D R & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of NGB Diagnostics Private Limited
NGB Diagnostics has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rakesh Kumar Maurya | Director | 05 Jun 2012 | 14 Years 4 Months | Current |
| Amit Singh Rawat | Director | 18 Aug 2016 | 10 Years 1 Months | Current |
Ownership and Shareholding of NGB Diagnostics Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of NGB Diagnostics Private Limited
NGB Diagnostics Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Legal Cases of NGB Diagnostics Private Limited
NGB Diagnostics Private Limited has 9 court cases on record: 8 filed by NGB Diagnostics, 1 filed against it. 1 case is pending and 8 are disposed. Status as checked between 21 Sep 2026 and 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 9 | 1 | 1 |
Cases on record (5 of 9)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Chennai, Tamil Nadu | Court case (COS) | Filed against the company by Lifecell International Private Limited | Pending |
| District court, Hyderabad CCC, Telangana | Execution petition | Filed by the company against Sandor Life Sciences Private Limited | Disposed |
| District court, Shahdara, Delhi | Execution petition | Filed by the company against Sandor Life Sciences Private Limited | Disposed |
| District court, Shahdara, Delhi | Interim or miscellaneous application | Filed by the company against Sandor Life Sciences Private Limited | Disposed |
| District court, Shahdara, Delhi | Commercial suit | Filed by the company against Sandor Life Sciences Private Limited | Disposed |
Full case history
All 9 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Associated Brands with NGB Diagnostics Private Limited
NGB Diagnostics operates one associated brand: NGB Diagnostics. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers next-generation sequencing and proteomic solutions for diagnostics and research. | ngbdx.com |
Employees and EPFO Compliance at NGB Diagnostics Private Limited
Employment history and EPFO contributions of people linked to NGB Diagnostics.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on NGB Diagnostics Private Limited
NGB Diagnostics Private Limited has 4 board changes on record since 2012: 2 appointments and 2 cessations. The latest: Amit Singh Rawat ceased to be Additional Director on 19 Sep 2016.
Credit Ratings, Litigation & Regulatory Alerts for NGB Diagnostics Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by NGB Diagnostics Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of NGB Diagnostics Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of NGB Diagnostics Private Limited
NGB Diagnostics has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAECN4454E1ZL | Delhi | Active | 01 Jul 2017 |
| 09AAECN4454E1ZH | Uttar Pradesh | Active | 15 Oct 2020 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of NGB Diagnostics Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NGB Diagnostics Private Limited
NGB Diagnostics is an active private limited company based in New Delhi, Delhi, India. The company works in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 05 June 2012 (14+ years old) and is registered under CIN U74999DL2012PTC236945.
NGB Diagnostics reported revenue of ₹1.93 Cr for FY 2025 (down 33% YoY).
NGB Diagnostics has 2 current directors:
- Rakesh Kumar Maurya - Director
- Amit Singh Rawat - Director
NGB Diagnostics reported a net profit of ₹3.68 Lakh (net margin 1.9%) and EBITDA of ₹7.16 Lakh (EBITDA margin 3.7%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of NGB Diagnostics is -27% over three years and 14% over five years. In the latest year (FY 2025) revenue fell 33%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of NGB Diagnostics is 07AAECN4454E1ZL, registered in Delhi. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 09AAECN4454E1ZH (Uttar Pradesh).
The CIN (Corporate Identification Number) of NGB Diagnostics is U74999DL2012PTC236945. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
NGB Diagnostics has 9 court cases on record: 8 filed by the company and 1 filed against it. 1 is pending.
NGB Diagnostics was incorporated on 05 June 2012, making it 14+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of NGB Diagnostics by revenue are Trident Imaging & Diagnostics Centre Private Limited, Fame Diagnostics & Health Care Private Limited, Chandrapur Imaging Centre and Medical Research Institute Private Limited, Newage Laboratories Limited, Neogen Diagnostics & Poly Clinic Private Limited and 5 more, all in the Healthcare industry (Diagnostics and Pathology Labs).
Amit Singh Rawat ceased to be Additional Director on 19 Sep 2016. Ashwani Kumar ceased to be Director on 19 Aug 2016. Amit Singh Rawat was appointed as Director on 18 Aug 2016. NGB Diagnostics has 4 board changes on record in total.